Literature DB >> 19285084

Crystal structures of the histo-aspartic protease (HAP) from Plasmodium falciparum.

Prasenjit Bhaumik1, Huogen Xiao, Charity L Parr, Yoshiaki Kiso, Alla Gustchina, Rickey Y Yada, Alexander Wlodawer.   

Abstract

The structures of recombinant histo-aspartic protease (HAP) from malaria-causing parasite Plasmodium falciparum as apoenzyme and in complex with two inhibitors, pepstatin A and KNI-10006, were solved at 2.5-, 3.3-, and 3.05-A resolutions, respectively. In the apoenzyme crystals, HAP forms a tight dimer not seen previously in any aspartic protease. The interactions between the monomers affect the conformation of two flexible loops, the functionally important "flap" (residues 70-83) and its structural equivalent in the C-terminal domain (residues 238-245), as well as the orientation of helix 225-235. The flap is found in an open conformation in the apoenzyme. Unexpectedly, the active site of the apoenzyme contains a zinc ion tightly bound to His32 and Asp215 from one monomer and to Glu278A from the other monomer, with the coordination of Zn resembling that seen in metalloproteases. The flap is closed in the structure of the pepstatin A complex, whereas it is open in the complex with KNI-10006. Although the binding mode of pepstatin A is significantly different from that in other pepsin-like aspartic proteases, its location in the active site makes unlikely the previously proposed hypothesis that HAP is a serine protease. The binding mode of KNI-10006 is unusual compared with the binding of other inhibitors from the KNI series to aspartic proteases. The novel features of the HAP active site could facilitate design of specific inhibitors used in the development of antimalarial drugs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19285084      PMCID: PMC2702178          DOI: 10.1016/j.jmb.2009.03.011

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  52 in total

1.  Structure of the Bacillus subtilis D-aminopeptidase DppA reveals a novel self-compartmentalizing protease.

Authors:  H Remaut; C Bompard-Gilles; C Goffin; J M Frère; J Van Beeumen
Journal:  Nat Struct Biol       Date:  2001-08

2.  Achiral, cheap, and potent inhibitors of Plasmepsins I, II, and IV.

Authors:  Christoph Boss; Olivier Corminboeuf; Corinna Grisostomi; Solange Meyer; Andrew F Jones; Lars Prade; Christoph Binkert; Walter Fischli; Thomas Weller; Daniel Bur
Journal:  ChemMedChem       Date:  2006-12       Impact factor: 3.466

3.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

4.  The three-dimensional structure of recombinant bovine chymosin at 2.3 A resolution.

Authors:  G L Gilliland; E L Winborne; J Nachman; A Wlodawer
Journal:  Proteins       Date:  1990

5.  Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-A resolution.

Authors:  P M Fitzgerald; B M McKeever; J F VanMiddlesworth; J P Springer; J C Heimbach; C T Leu; W K Herber; R A Dixon; P L Darke
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

6.  Structures of Ser205 mutant plasmepsin II from Plasmodium falciparum at 1.8 A in complex with the inhibitors rs367 and rs370.

Authors:  Oluwatoyin A Asojo; Elena Afonina; Sergei V Gulnik; Betty Yu; John W Erickson; Ramnarayan Randad; Djamel Medjahed; Abelardo M Silva
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-11-23

7.  Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.

Authors:  Koushi Hidaka; Tooru Kimura; Adam J Ruben; Tsuyoshi Uemura; Mami Kamiya; Aiko Kiso; Tetsuya Okamoto; Yumi Tsuchiya; Yoshio Hayashi; Ernesto Freire; Yoshiaki Kiso
Journal:  Bioorg Med Chem       Date:  2008-10-10       Impact factor: 3.641

8.  Is histoaspartic protease a serine protease with a pepsin-like fold?

Authors:  N Andreeva; P Bogdanovich; I Kashparov; M Popov; M Stengach
Journal:  Proteins       Date:  2004-05-15

9.  KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic.

Authors:  T Mimoto; J Imai; S Tanaka; N Hattori; S Kisanuki; K Akaji; Y Kiso
Journal:  Chem Pharm Bull (Tokyo)       Date:  1991-11       Impact factor: 1.645

10.  Locking the two ends of tetrapeptidic HTLV-I protease inhibitors inside the enzyme.

Authors:  Meihui Zhang; Jeffrey-Tri Nguyen; Henri-Obadja Kumada; Tooru Kimura; Maosheng Cheng; Yoshio Hayashi; Yoshiaki Kiso
Journal:  Bioorg Med Chem       Date:  2008-05-28       Impact factor: 3.641

View more
  19 in total

Review 1.  Malaria parasite plasmepsins: More than just plain old degradative pepsins.

Authors:  Armiyaw S Nasamu; Alexander J Polino; Eva S Istvan; Daniel E Goldberg
Journal:  J Biol Chem       Date:  2020-05-04       Impact factor: 5.157

2.  Deciphering the mechanism of potent peptidomimetic inhibitors targeting plasmepsins - biochemical and structural insights.

Authors:  Vandana Mishra; Ishan Rathore; Anagha Arekar; Lakshmi Kavitha Sthanam; Huogen Xiao; Yoshiaki Kiso; Shamik Sen; Swati Patankar; Alla Gustchina; Koushi Hidaka; Alexander Wlodawer; Rickey Y Yada; Prasenjit Bhaumik
Journal:  FEBS J       Date:  2018-07-07       Impact factor: 5.542

3.  Structural insights into the activation and inhibition of histo-aspartic protease from Plasmodium falciparum.

Authors:  Prasenjit Bhaumik; Huogen Xiao; Koushi Hidaka; Alla Gustchina; Yoshiaki Kiso; Rickey Y Yada; Alexander Wlodawer
Journal:  Biochemistry       Date:  2011-09-26       Impact factor: 3.162

Review 4.  Structural studies of vacuolar plasmepsins.

Authors:  Prasenjit Bhaumik; Alla Gustchina; Alexander Wlodawer
Journal:  Biochim Biophys Acta       Date:  2011-04-20

5.  Crystal structures of the free and inhibited forms of plasmepsin I (PMI) from Plasmodium falciparum.

Authors:  Prasenjit Bhaumik; Yasumi Horimoto; Huogen Xiao; Takuya Miura; Koushi Hidaka; Yoshiaki Kiso; Alexander Wlodawer; Rickey Y Yada; Alla Gustchina
Journal:  J Struct Biol       Date:  2011-04-20       Impact factor: 2.867

6.  Evaluation of antiplasmodial activity in silico and in vitro of N-acylhydrazone derivatives.

Authors:  Fernanda A Oliveira; Ana Claudia S Pinto; Caique L Duarte; Alex G Taranto; Eder Lorenzato Junior; Cleydson Finotti Cordeiro; Diogo T Carvalho; Fernando P Varotti; Amanda L Fonseca
Journal:  BMC Chem       Date:  2022-07-09

7.  FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane.

Authors:  Derek F Ceccarelli; Sofiia Ivantsiv; Amber Anne Mullin; Etienne Coyaud; Noah Manczyk; Pierre Maisonneuve; Igor Kurinov; Liang Zhao; Chris Go; Anne-Claude Gingras; Brian Raught; Sabine Cordes; Frank Sicheri
Journal:  Structure       Date:  2019-05-02       Impact factor: 5.006

8.  Computational perspectives into plasmepsins structure-function relationship: implications to inhibitors design.

Authors:  Alejandro Gil L; Pedro A Valiente; Pedro G Pascutti; Tirso Pons
Journal:  J Trop Med       Date:  2011-07-03

9.  Activation mechanism of plasmepsins, pepsin-like aspartic proteases from Plasmodium, follows a unique trans-activation pathway.

Authors:  Ishan Rathore; Vandana Mishra; Chandan Patel; Huogen Xiao; Alla Gustchina; Alexander Wlodawer; Rickey Y Yada; Prasenjit Bhaumik
Journal:  FEBS J       Date:  2020-05-26       Impact factor: 5.622

10.  Molecular modeling and prediction of binding mode and relative binding affinity of Art-Qui-OH with P. falciparum Histo-Aspartic Protease (HAP).

Authors:  Rajani Kanta Mahapatra; Niranjan Behera; Pradeep Kumar Naik
Journal:  Bioinformation       Date:  2012-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.